Pharma major Lupin Limited and global biopharmaceutical company AbbVie Inc., today announced that AbbVie has licensed Lupin's MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation ...

Indian drug maker Lupin Ltd <LUPN.BO> said on Wednesday it had acquired a majority stake in Japanese generic drug maker Kyowa Pharmaceutical Industry Co Ltd. It did not give financial details but ...